The aim of the study was to analyze bacterial flora in venous leg ulcers, empiric and targeted antibiotic therapy, and factors influencing healing time.
Materials and methods
Data from 30 patients with venous leg ulcers were retrospectively analyzed. Collected data included: sociodemographic data, wounds information, number of comorbidities, results of the microbiological examination, and empiric and targeted antibiotic therapy. To compare the empiric and targeted treatment in terms of their compatibility, the group of patients was divided into the four subgroups: NEA (no empiric antibiotics), NA (no antibiotics), ETA+ (compatibility of empiric and targeted antibiotic), ETA− (no compatibility of empiric and targeted antibiotic).
Results
The average ulcer healing time was 163.4 ± 97.1 (range 51.0 to 426.0) days and increased by 28 days with each additional bacterial strain in the ulcer (p = 0.041). Healing time did not differ between the four groups. Staphylococcus aureus and Pseudomonas aeruginosa were the most frequent bacteria. Amoxicillinium/acidum clavulanicum was the most common empirical antibiotic and amoxicillinium/acidum clavulanicum, and levofloxacinum was the most common targeted antibiotic.
Conclusions
Venous leg ulcer healing time was prolonged with each subsequent bacterial strain in the ulcer, and it was independent from systemic antibiotic therapy.
StaceyM. Chronic venous insufficiency and leg ulceration: principles and vascular biology. In: Fitridge R, Thomson M (eds) Mechanism of vascular disease: a reference book for vascular specialist. Vol. 25. Australia: University of Adelaide Press, 2011, pp.459–474.
5.
MervisJSKirsnerRSLev-TovH.Protocol for a longitudinal cohort study: determination of risk factors for the development of first venous leg ulcer in people with chronic venous insufficiency, the VEINS (venous insufficiency in South Florida) cohort. BMJ Open2019;
9: e023313.
6.
MaronaHKornobisA.Patofizjologia rozwoju żylaków oraz wybrane metody ich leczenia – aktualny stan wiedzy. Post Farmakoter2009;
65: 88–92.
7.
PuglieseDJ.Infection in venous leg ulcers: considerations for optimal management in the elderly. Drugs Aging2016;
33: 87–96.
8.
YounYJLeeJ.Chronic venous insufficiency and varicose veins of the lower extremities. Korean J Intern Med2019;
34: 269–283.
9.
AshbyRLGabeRAliS, et al.
Clinical and cost-effectiveness of compression hosiery versus compression bandages in treatment of venous leg ulcers (venous leg ulcer study IV, VenUS IV): a randomised controlled trial. Lancet2014;
383: 871–879.
10.
Woźnicka-LeśkiewiczLPosadzy-MałaczyńskaA.Ankle-brachial index (ABI) as a basic tool in the evaluation of peripheral arteries and cardiovascular risk in general practice. Med Rodz2017;
20: 143–147.
11.
JawieńABartoszewiczMPrzondo-MordarskaA, et al.
Wytyczne postępowania miejscowego i ogólnego w ranach objętych procesem infekcji. Leczenie Ran2012;
9: 59–75.
12.
NieckulaMDębskaGSzewczykA.The role of the primary health-care nurse providing home nursing service to patients with venous ulcers of lower limbs. Piel Zdr Publ2015;
5: 111–119.
13.
PotempaMJonczykPJanerkaM, et al.
Rany przewlekłe – epidemiologia i czynniki wpływające na proces gojenia. Leczenie Ran2014;
11: 43–50.
14.
CheatleTRScottHJ.Owrzodzenie żylne – rys historyczny. In: Smith PDColeridge (eds) Mikrokrążenie w chorobach żył.
Vol. 1.
Gdańsk: Via medica, 2000, pp.1–18.
15.
The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. version 9.0. Swden: The European Committee on Antimicrobial Susceptibility Testing.
16.
MiriagouVTzelepiEKotsakisSD, et al.
Combined disc methods for the detection of KPC- and/or VIM-positive Klebsiella pneumoniae: improving reliability for the double carbapenemase producers. Clin Microbiol Infect2013;
19: E412–E415.
17.
NordmannPPoirelLDortetL.Rapid detection of carbapenemase-producing enterobacteriaceae. Emerg Infect Dis2012;
18: 1503–1507.
18.
PatersonDLBonomoRA.Extended-spectrum β-lactamases: a clinical update. Clin Microbiol Rev2005;
18: 657–686.
19.
The European Committee on Antimicrobial Susceptibility Testing. The EUCAST guideline on detection of resistance mechanisms. v1.0 (2013-12-11). Sweden: The European Committee on Antimicrobial Susceptibility Testing.
20.
R Core Team2019. R: a language and environment for statistical computing.
Vienna, Austria:
R Foundation for Statistical Computing.
WickhamH.ggplot2: elegant graphics for data analysis.
New York,
Springer-Verlag: 2016.
23.
ShuklaVKShuklaDTripathiAK, et al.
Results of a one-day, descriptive study of quality of life in patients with chronic wounds. Ostomy Wound Manage2008;
54: 43–49.
24.
SkeneAISmithJMDoréCJ, et al.
Venous leg ulcers: a prognostic index to predict time to healing. BMJ1992;
305: 1119–1121.
25.
ZolotukhinIASeliverstovEIShevtsovYN, et al.
Prevalence and risk factors for chronic venous disease in the general Russian population. Eur J Vasc Endovasc Surg2017;
54: 752–758.
26.
BartoszewiczMJunkaA.Biofilm based wound care: strategy for the treatment of chronic wounds affected by the infection caused by microorganisms in the form of biofilms. Leczenie Ran2012;
9: 1–6.
27.
RahimKSalehaSZhuX, et al.
Bacterial contribution in chronicity of wounds. Microb Ecol2017;
73: 710–721.
28.
CreagerMALoscalzoJ.Chronic venous disease and lymphaedema. In: KasperDLHauserSLJamesonJL, et al. (eds) Harrison’s principles of internal medicine. 19th ed.
New York: McGraw Hill Education, 2015, pp.1650–1655.
29.
O’MearaSRichardsonRLipskyBA.Topical and systemic antimicrobial therapy for venous leg ulcers. JAMA2014;
311: 2534–2535.
30.
HryniewiczWKuligJOzorowskiT.Stosowanie antybiotyków w zakażeniach skóry i tkanek miękkich. Warszawa: Narodowy Program Ochrony Antybiotyków, 2012, pp.12–20.
31.
LimTSMwipatayiBPMurrayR, et al.
Microbiological profile of chronic ulcers of the lower limb: a prospective observational cohort study. ANZ J Surg2006;
76: 688–692.
32.
TzanevaVMladenovaITodorovaG, et al.
Antibiotic treatment and resistance in chronic wounds of vascular origin. Clujul Med2016;
89: 365–370.
33.
GjodsbolKChristensenJJKarlsmarkT, et al.
Multiple bacterial species reside in chronic wounds: a longitudinal study. Int Wound Journal2006;
3: 225–231.
34.
EngelbergWLDorlerMStuckerM, et al.
Impact of gram-negative bacteria on the treatment of venous leg ulcers. Int Wound J2018;
15: 958–965.
35.
SerraRGrandeRButricoL, et al.
Chronic wound infections: the role of Pseudomonas aeruginosa and Staphylococcus aureus. Expert Rev Anti Infect Ther2015;
13: 605–613.
